Reports Q3 revenue $173.6M, consensus $181.52M.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPK:
- Aspira Women’s Health expands collaboration with Bioreference
- Is OPK a Buy, Before Earnings?
- ModeX secures $35M BARDA supplement to develop COVID antibodies
- NextPlat gets four-year extension of OPKO Healthcare e-commerce program in China
- Entera Bio, Opko Health provide update on PK/PD results of GLP-1/Glucagon